Updated: Sep 14, 2009
Replantation aims to restore the amputated part to its anatomical site, preserving function and appearance. Outcome depends on factors intrinsic to the patient and to the nature of the injury. Young patients who have distal, cleanly amputated extremities have the best return of function; multiple levels of injury, crush, or avulsing injuries have less. Patients must be fully informed about the commitment to rehabilitation and the possibility of multiple surgeries needed for best results.
In the past 200 years, successful replantation of amputated digits has gradually moved from fantasy to reality. William Balfour performed the first successful fingertip reattachment in 1814; Thomas Hunter is credited with the first thumb replantation performed in the following year.
Little progress was made until the pioneering work of William Steward Halstead and Alexis Carrel, who performed replantation experiments with dog limbs in the 1880s. Dr Carrel won the Nobel Prize in 1912 for his work on vascular anastomoses and for pioneering renal transplantation.
In 1962, Ronald A. Malt performed the first successful replantation of an entire limb in a 12-year-old boy whose arm had been severed in a train accident. With the development of the operating microscope by Julius Jacobson and Ernesto Suarez in the early 1960s, replantation became easier, and its use began to spread throughout the Western world.
With the advent of microvascular reanastomosis, digit replantation became tenable. In 1965, Shigeo Kmatsu and Susumu Tamai were the first to perform such a procedure. Since then, medicine has advanced to include the successful replantation of a child’s completely amputated ear as well as replantation of multiple digits and hands.1,2Amputation replantation is the reattachment of a completely severed part. This is distinguished from incomplete nonviable amputations, which require revascularization. Revascularization is the reconstruction of the blood supply of an incompletely amputated part. In general, revascularization usually provides better functional results than replantation itself.
However, viability alone is an inadequate measure of success. The main predictive factors include injury mechanism (crushing and avulsion have the worst prognosis), platelet count, smoking after operation, preservation method of amputated part, and the use of vein grafting.4 The amputations of the distal phalanx and the thumb, male gender, and ischemia time greater than 12 hours along with presence of diabetes seem to portend a somewhat worse prognosis. Age and history of alcohol use are less significant factors toward the success of replantation.5
As replantation techniques advance, and success rates increase regardless of adverse factors, the focus is shifting from merely achieving anatomic survival through adequate tissue perfusion, to reconstruction of a functional limb. In some instances, a hand with a well-formed stump may be more functional than one with a functionless digit. The goal of replantation should not be the indiscriminate replantation of all severed fingers but the preservation of quality of life through regained function and appearance.
An adequate history of the amputation injury is important and should include the mechanism, time, and place of injury; condition of the injured part; hand dominance; and general condition of the patient.
The 6 mechanisms of amputation injury are the following:
Consult a microvascular hand surgeon.
Prophylactic antibiotics are indicated with amputation, crush, or degloving injuries. Devitalized tissue is a good culture medium for bacterial contaminants. Common pathogens are Staphylococcus aureus (most likely organism) and group A streptococci, whereas clostridia species and organisms from the Enterobacteriaceae family are less common. Gram-negative and anaerobic bacteria are more commonly found with extensive tissue damage or with wounds grossly contaminated with soil, saliva, or feces. In these cases, perform Gram staining and cultures before initiating antibiotic therapy.
If the amputation is from a human bite, antibiotic coverage should include streptococci, Eikenella corrodens, anaerobic bacteria, and staphylococci. Use oral amoxicillin and clavulanate for human bites without amputation. Use intravenous ampicillin and sulbactam or ticarcillin and clavulanate for amputations or established infections caused by human bites. A combination of penicillin G and an antistaphylococcal antibiotic is also acceptable for minor bite wounds.
Empiric antimicrobial therapy must be comprehensive and should cover all likely pathogens.
First-generation semisynthetic cephalosporin; binds one or more penicillin-binding proteins; arrests bacterial cell-wall synthesis and inhibits bacterial growth; primarily active against skin flora, including S aureus.
500-1500 mg IV/IM q6-8h; not to exceed 100 mg/kg/d
25-50 mg/kg/d IV/IM divided tid/qid
Probenecid decreases renal clearance and prolongs effect; concurrent use with aminoglycosides may increase renal toxicity; may yield a false-positive result for glucose with urine dipstick testing
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Adjust dose in patients with renal impairment
Drug combination that involves a beta-lactamase inhibitor with ampicillin; covers skin organisms, enteric flora, and anaerobes; not ideal for nosocomial pathogens.
1.5 g (1 g ampicillin with 0.5 g sulbactam) to 3 g (2 g ampicillin with 1 g sulbactam) IV/IM q6h; not to exceed 4 g/d sulbactam or 8 g/d ampicillin
<3 months: Not established
3 months to 12 years: ampicillin 100-200 mg/kg/d (150-300 mg Unasyn) IV divided q6h
>12 years: Administer as in adults
Probenecid and disulfiram decrease renal excretion of ampicillin and sulbactam and increase levels of the antibiotics; allopurinol increases ampicillin excretion; may potentiate ampicillin rash and decrease the effect of oral contraceptives
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Adjust dose in patients with renal failure; evaluate rash and differentiate from hypersensitivity reaction
Inhibits biosynthesis of cell wall mucopeptide and is effective during stage of active growth; antipseudomonal penicillin and a beta-lactamase inhibitor covers most gram-positive and gram-negative organisms, as well as anaerobes.
3.1 g IV q4-6h; not to exceed 18-24 g/d
100 mg/kg/dose IV q8h
Tetracyclines may decrease the effects of ticarcillin; high concentrations of ticarcillin may physically inactivate aminoglycosides if they are administered in same IV line; effects when administered with aminoglycosides are synergistic; probenecid may increase penicillin levels
Documented hypersensitivity; do not treat severe pneumonia, bacteremia, pericarditis, emphysema, meningitis, and purulent or septic arthritis with oral penicillin during the acute stage
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Obtain complete blood count before therapy and at least weekly during therapy; monitor for liver function abnormalities by measuring aspartate transaminase (AST) and alanine transaminase (ALT) during therapy; exercise caution in patients with hepatic insufficiencies; perform urinalysis, and determine blood urea nitrogen and creatinine levels during therapy, and adjust dose if values become elevated; monitor blood levels to avoid possible neurotoxic reactions
Pain control is essential to quality patient care, ensuring patient comfort and promoting pulmonary toilet. Most analgesics have sedating properties, which are beneficial for patients with painful skin lesions.
More potent narcotic analgesic with a much shorter half-life than morphine sulfate; drug of choice for conscious sedation analgesia; ideal for analgesic action of short duration during anesthesia and in immediate postoperative period. For patient needing long-term pain control, sustained-release fentanyl transdermal patch (Duragesic) may control pain with 72-h dosing intervals; some patients require dosing intervals of 48 h. Onset of transdermal fentanyl patch analgesia is delayed for 8-12 hours, so acute pain control must be provided prior to full effect of patch. Overdose has been reported, so start with lowest dose/hour patch (25 mcg/h).
1 mcg (0.001 mg)/kg IV/IM q30min to q2h prn
(50-100 mcg IV q1-2h prn; alternatively 0.5-1.5 mcg/kg/h IV infusion)
1-3 years:
Dose: 2-3 mcg/kg IV q1-4h prn; alternatively 1-2 mcg/kg IV X 1, then 0.5-1 mcg/kg/h infusion; titrate upward
3-12 years:
Dose: 1-2 mcg/kg IV q1-4h prn; alternatively 1-2 mcg/kg IV X 1, then 0.5-1 mcg/kg/h infusion; titrate upward
>12 years: Administer as in adults
Phenothiazines may antagonize analgesic effects of opiate agonists; tricyclic antidepressants may potentiate adverse effects when both drugs are used concurrently
Documented hypersensitivity; respiratory depression; constipation; nausea; emesis; urinary retention; hypotension; potentially compromised airway that would make it difficult to establish airway control rapidly
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Caution in hypotension, respiratory depression, constipation, nausea, emesis, or urinary retention; idiosyncratic reaction, known as chest wall rigidity syndrome, may require neuromuscular blockade to increase ventilation
Drug of choice for narcotic analgesia because of its reliable and predictable effects, safety profile, and ease of reversibility with naloxone. Various IV doses are used and are commonly titrated until desired effect is obtained.
4-10 mg bolus slow IV; may repeat to maximum of 30 mg for severe pain
0.1-0.2 mg/kg slow IV/IM
Phenothiazines may antagonize analgesic effects of opiate agonists; tricyclic antidepressants, MAOIs, and other CNS depressants may potentiate adverse effects
Documented hypersensitivity; respiratory depression; nausea; emesis; constipation; urinary retention; hypotension; potentially compromised airway that would make it difficult establish airway control rapidly
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Caution in atrial flutter and other supraventricular tachycardias; vagolytic action may increase the ventricular response rate
Black Box Warning
Abuse potential: Opioid agonist schedule II controlled substance
Shen XQ, Wang C, Xu JH, Wu SC. Successful microsurgical replantation of a child's completely amputated ear. J Plast Reconstr Aesthet Surg. Dec 2008;61(12):e19-22. [Medline].
Ihrai T, Balaguer T, Monteil MC, et al. [Surgical management of traumatic ear amputations: literature review]. Ann Chir Plast Esthet. Apr 2009;54(2):146-51. [Medline].
Salah MM, Khalid KN. Replantation of multiple digits and hand amputations: four case reports. Cases J. Oct 23 2008;1(1):266. [Medline].
Dec W. A meta-analysis of success rates for digit replantation. Tech Hand Up Extrem Surg. Sep 2006;10(3):124-9. [Medline].
Li J, Guo Z, Zhu Q, et al. Fingertip replantation: determinants of survival. Plast Reconstr Surg. Sep 2008;122(3):833-9. [Medline].
Schumer E, Friedman FD. Pulse oximetry for preoperative vascular assessment in a thumb near-amputation. J Emerg Med. Nov-Dec 1995;13(6):753-5. [Medline].
Wilhelmi BJ, Lee WP, Pagenstert GI, Pagensteert GI, May JW Jr. Replantation in the mutilated hand. Hand Clin. Feb 2003;19(1):89-120. [Medline].
Azzopardi EA, Whitaker IS, Laing H. Perceptions of correct preoperative storage and transfer of amputated digits: a national survey of referring emergency departments. J Plast Reconstr Aesthet Surg. Nov 2008;61(11):1418-9. [Medline].
Lloyd MS, Teo TC, Pickford MA, Arnstein PM. Preoperative management of the amputated limb. Emerg Med J. Jul 2005;22(7):478-80. [Medline].
Chai Y, Kang Q, Yang Q, Zeng B. Replantation of amputated finger composite tissues with microvascular anastomosis. Microsurgery. 2008;28(5):314-20. [Medline].
Hattori Y, Doi K, Ikeda K, Abe Y, Dhawan V. Significance of venous anastomosis in fingertip replantation. Plast Reconstr Surg. Mar 2003;111(3):1151-8. [Medline].
Oufquir A, Bakhach J, Panconi B, Guimberteau JC, Baudet J. [Salvage of digits replantations by direct arterial antithrombotic infusion]. Ann Chir Plast Esthet. Dec 2006;51(6):471-81. [Medline].
Yan H, Jackson WD, Songcharoen S, et al. Vein grafting in fingertip replantations. Microsurgery. 2009;29(4):275-81. [Medline].
Ridha H, Jallali N, Butler PE. The use of dextran post free tissue transfer. J Plast Reconstr Aesthet Surg. 2006;59(9):951-4. [Medline].
Colwell AS, Buntic RF, Brooks D, Wright L, Buncke GM, Buncke HJ. Detection of perfusion disturbances in digit replantation using near-infrared spectroscopy and serial quantitative fluoroscopy. J Hand Surg Am. Mar 2006;31(3):456-62. [Medline].
Adani R, Castagnetti C, Landi A. Degloving injuries of the hand and fingers. Clin Orthop Relat Res. May 1995;19-25. [Medline].
Askari M, Fisher C, Weniger FG, Bidic S, Lee WP. Anticoagulation therapy in microsurgery: a review. J Hand Surg Am. May-Jun 2006;31(5):836-46. [Medline].
Battiston B, Tos P, Clemente A, Pontini I. Actualities in big segments replantation surgery. J Plast Reconstr Aesthet Surg. 2007;60(7):849-55. [Medline].
Brooks D, Buntic RF, Kind GM, Schott K, Buncke GM, Buncke HJ. Ring avulsion: injury pattern, treatment, and outcome. Clin Plast Surg. Apr 2007;34(2):187-95, viii. [Medline].
Buntic RF, Brooks D, Buncke GM. Index finger salvage with replantation and revascularization: revisiting conventional wisdom. Microsurgery. 2008;28(8):612-6. [Medline].
Buntic RF, Siko PP, Buncke GM, Ruebeck D, Kind GM, Buncke HJ. Using the Internet for rapid exchange of photographs and X-ray images to evaluate potential extremity replantation candidates. J Trauma. Aug 1997;43(2):342-4. [Medline].
Chiu HY, Shieh SJ, Hsu HY. Multivariate analysis of factors influencing the functional recovery after finger replantation or revascularization. Microsurgery. 1995;16(10):713-7. [Medline].
Datiashvili RO, Knox KR, Kaplan GM. Solutions to challenging digital replantations. Clin Plast Surg. Apr 2007;34(2):167-75, vii. [Medline].
Dautel G, Barbary S. Mini replants: fingertip replant distal to the IP or DIP joint. J Plast Reconstr Aesthet Surg. 2007;60(7):811-5. [Medline].
Hattori Y, Doi K, Sakamoto S, Yamasaki H, Wahegaonkar A, Addosooki A. Fingertip replantation. J Hand Surg [Am]. Apr 2007;32(4):548-55. [Medline].
Hierner R, Berger AK. Long-term results after vascularised joint transfer for finger joint reconstruction. J Plast Reconstr Aesthet Surg. Nov 2008;61(11):1338-46. [Medline].
Hierner R, Berger AK, Frederix PR. Lower leg replantation--decision-making, treatment, and long-term results. Microsurgery. 2007;27(5):398-410. [Medline].
Hoang NT, Staudenmaier R, Hoehnke C. Case reports: thumb reconstruction using amputated fingers. Clin Orthop Relat Res. Aug 2008;466(8):1996-2001. [Medline].
Hyza P, Vesely J, Drazan L, Stupka I, Ranno R, Castagnetti F. Primary vein grafting in treatment of ring avulsion injuries: a 5-year prospective study. Ann Plast Surg. Aug 2007;59(2):163-7. [Medline].
Kocher MS. History of replantation: from miracle to microsurgery. World J Surg. May-Jun 1995;19(3):462-7. [Medline].
Medling BD, Bueno RA Jr, Russell RC, Neumeister MW. Replantation outcomes. Clin Plast Surg. Apr 2007;34(2):177-85, vii-viii. [Medline].
Merle M, Dautel G. Advances in digital replantation. Clin Plast Surg. Jan 1997;24(1):87-105. [Medline].
Mihara M, Nakanishi M, Nakashima M, Narushima M, Gonda K, Koshima I. Distal phalanx replantation using the delayed venous method: a high success rate in 21 cases without specialised technique. J Plast Reconstr Aesthet Surg. 2008;61(1):88-93. [Medline].
Molski M. Replantation of fingers and hands after avulsion and crush injuries. J Plast Reconstr Aesthet Surg. 2007;60(7):748-54. [Medline].
Narushima M, Mihara M, Koshima I, et al. Intravascular stenting (IVaS) method for fingertip replantation. Ann Plast Surg. Jan 2009;62(1):38-41. [Medline].
Paavilainen P, Nietosvaara Y, Tikkinen KA, Salmi T, Paakkala T, Vilkki S. Long-term results of transmetacarpal replantation. J Plast Reconstr Aesthet Surg. 2007;60(7):704-9. [Medline].
Partington MT, Lineaweaver WC, O'Hara M, Kitzmiller J, Valauri FA, Oliva A. Unrecognized injuries in patients referred for emergency microsurgery. J Trauma. Feb 1993;34(2):238-41. [Medline].
Povlsen B, Nylander G, Nylander E. Natural history of digital replantation: a 12-year prospective study. Microsurgery. 1995;16(3):138-40. [Medline].
Rockwell WB, Haidenberg J, Foreman KB. Thumb replantation using arterial conduit graft and dorsal vein transposition. Plast Reconstr Surg. Sep 2008;122(3):840-3. [Medline].
Sabapathy SR, Venkatramani H, Bharathi RR, Dheenadhayalan J, Bhat VR, Rajasekaran S. Technical considerations and functional outcome of 22 major replantations (The BSSH Douglas Lamb Lecture, 2005). J Hand Surg Eur Vol. Oct 2007;32(5):488-501. [Medline].
Schlenker JD, Koulis CP. Amputations and replantations. Emerg Med Clin North Am. Aug 1993;11(3):739-53. [Medline].
Shah AK, Schreuder FB. Reconstruction of circulation in the fingertip without vein repair in zone I replantation: reconstruction or reduction?. J Hand Surg [Am]. Mar 2009;34(3):579; author reply 580. [Medline].
Sharma S, Lin S, Panozzo A, Tepper R, Friedman D. Thumb replantation: a retrospective review of 103 cases. Ann Plast Surg. Oct 2005;55(4):352-6. [Medline].
Sood R, Bentz ML, Shestak KC, Browne EZ Jr. Extremity replantation. Surg Clin North Am. Apr 1991;71(2):317-29. [Medline].
Sudhagar G, Le Blanc M. A thermoplastic thumb splint after amputation of the thumb. J Hand Ther. Jan-Mar 2009;22(1):88-91. [Medline].
Tian L, Tian F, Tian F, Li X, Ji X, Wei J. Replantation of completely amputated thumbs with venous arterialization. J Hand Surg [Am]. Sep 2007;32(7):1048-52. [Medline].
Troum S, Floyd WE 3rd. Upper extremity replantation at a regional medical center: a six-year review. Am Surg. Sep 1995;61(9):836-9. [Medline].
Wang H. Secondary surgery after digit replantation: its incidence and sequence. Microsurgery. 2002;22(2):57-61. [Medline].
Woon CY, Lee JY, Teoh LC. Resurfacing hemipulp losses of the thumb: the cross finger flap revisited: indications, technical refinements, outcomes, and long-term neurosensory recovery. Ann Plast Surg. Oct 2008;61(4):385-91. [Medline].
Zhang X, Wen S, Wang B, Wang Q, Li C, Zhu H. Reconstruction of circulation in the fingertip without vein repair in zone I replantation. J Hand Surg [Am]. Nov 2008;33(9):1597-601. [Medline].
replantation, amputated digits, amputated finger, amputated toe, amputation injury, amputation, amputated, digital replantation, severed finger, severed limb, severed toe, red-line sign, ribbon sign, avulsion, crush avulsion, toe-to-thumb transfer
Mark I Langdorf, MD, MHPE, FAAEM, FACEP, RDMS, Professor of Clinical Emergency Medicine, Department Chair, Associate Residency Director, Department of Emergency Medicine, University of California at Irvine
Mark I Langdorf, MD, MHPE, FAAEM, FACEP, RDMS is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, Council of Emergency Medicine Residency Directors, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
J Akiva Kahn, MA, University of California, Irvine, School of Medicine
J Akiva Kahn, MA is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Student Association/Foundation, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Assaad J Sayah, MD, Chief, Department of Emergency Medicine, Cambridge Health Alliance
Assaad J Sayah, MD is a member of the following medical societies: National Association of EMS Physicians
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment
Eric L Legome, MD, Chair, Department of Emergency Medicine, St Vincent's Hospital Manhattan; Associate Professor, Department of Emergency Medicine, New York Medical College
Eric L Legome, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, Council of Emergency Medicine Residency Directors, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Rick Kulkarni, MD, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital
Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: WebMD Salary Employment